STAT
MARCH 28, 2025
Food programs in poor neighborhoods. People to track surges of Covid, measles, or other diseases. Programs to help people with addiction. The cascade of budget cuts from Washington has hundreds of state and local health officials around the country struggling to assess the impact on their communities and departments.
The Pharmacist
MARCH 28, 2025
Community pharmacy funding negotiations have concluded, with the deal set to be announced on Monday, Community Pharmacy England has said. It comes as the economic analysis of community pharmacy has been published, which was due to happen after negotiations concluded. In response, CPE told The Pharmacist: 'Now that CPCF [Community Pharmacy Contractual Framework] negotiations have […] The post Community pharmacy negotiations concluded, announcement set for Monday appeared first on The Pharma
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 28, 2025
WASHINGTON — Keith Joung knows better than a lot of people what, exactly, it might require to prove to regulators and patients that CRISPR could be safely used to alter the genome of a human embryo. If, of course, society decided that was a good idea. Joung, an early pioneer of the gene-editing technology, was the first to show CRISPR could target and cut DNA inside an embryo — in zebrafish — back in 2013.
PharmaVoice
MARCH 28, 2025
The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 28, 2025
In a blow to the pharmaceutical industry, a U.S. court judge ruled that a Colorado state board can proceed with plans to place limits on the prices paid for medicines, the first such decision to support the controversial attempts by some states to control their prescription drug spending. The case had been filed last year by Amgen after the state Prescription Drug Affordability Board determined that its big-selling medication called Enbrel is unaffordable and began a process to create a so-calle
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MARCH 28, 2025
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharma Marketing Network
MARCH 28, 2025
Introduction Weekends may be synonymous with relaxation, but for pharma marketing professionals, they offer an unmatched window to recalibrate. When deadlines arent looming and inboxes arent overflowing, theres finally time to revisit trends, read strategy insights, and uncover tools to elevate your marketing game. The Pharma Marketing Network serves as an ideal destination for this kind of weekend deep-dive.
STAT
MARCH 28, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The Department of Health and Human Services is cutting 20,000 employees. It’s a chaotic time. Help us sift through the information and submit an anonymous tip here.
European Pharmaceutical Review
MARCH 28, 2025
The global pharmaceutical & biotechnology environmental monitoring market is expected to expand with a CAGR of 6.2 percent between 2025 and 2031, according a report by Lucintel. Several factors are fuelling this growth, including greater adoption of advanced innovations such as cloud technology, which are driving efficiencies and accuracy, the research highlighted.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
MARCH 28, 2025
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal the verdict, a strategy successfully employed by Eisai.
Express Pharma
MARCH 28, 2025
Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Dr. Reddys Laboratories SA, wholly-owned subsidiary of Dr. Reddys Laboratories, announce they have reached commercialisation and license agreements for BAT2206, a proposed Stelara Biosimilar, and BAT2506, a proposed Simponi Biosimilar.
BioPharma Dive
MARCH 28, 2025
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.
pharmaphorum
MARCH 28, 2025
Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
BioPharma Dive
MARCH 28, 2025
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.
pharmaphorum
MARCH 28, 2025
Fast-growing pharma group Chiesi has revealed plans to spend 430m on a new therapeutics manufacturing facility at its site in Milan
BioPharma Dive
MARCH 28, 2025
Novo is paying up to $1 billion for a “non-incretin” medicine that might boost Wegovy’s effects. Elsewhere, Arbutus laid off 57% of its workforce and Bicycle Therapeutics shook up its leadership team.
pharmaphorum
MARCH 28, 2025
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
BioPharma Dive
MARCH 28, 2025
The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s board still supports.
Pharmafile
MARCH 28, 2025
Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, monitoring and calibration products and services to the life sciences industry. Sved will formally join the company in June, with chief financial officer Andreas Morthorst acting as interim CEO. Sved is a healthcare and life […] The post Gergely Sved appointed as CEO of Ellab appeared first on Pharmafile.
Pharmaceutical Technology
MARCH 28, 2025
The Macau Special Administrative Region (ISAF) Pharmaceutical Administration Bureau has approved IASO Bio's NDA for equecabtagene autoleucel.
Pharmafile
MARCH 28, 2025
Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo direct cell reprogramming for cancer immunology. Olwill specialises in immunology drug development. In his new position, he will lead Investigational New Drug (IND)-enabling studies and clinical trials planning for Asgards AT-108 therapy.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
MARCH 28, 2025
The latest news for pharma industry insiders.
Pharmafile
MARCH 28, 2025
Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is a biotechnology company that designs and develops molecular vectors allowing targeted delivery of therapeutic molecules and imaging agents to organs. Imbert specialises in financial management and structuring. She previously served as head of financial and […] The post Carole Imbert appointed as CFO of Vect-Horus appeared first on Pharmafile.
World Pharma News
MARCH 28, 2025
A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai. Once adapted to treat humans, the technique could potentially be used to repair heart muscle damage after a heart attack and be applied to a variety of inflammatory disorders.
PharmaTech
MARCH 28, 2025
Colbert Packaging specializes in safe, smart, and sustainable paperboard packaging for the pharmaceutical and healthcare industries, differentiating itself through industry-focused investments and a commitment to environmental responsibility.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Commerce
MARCH 28, 2025
Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support are working to evolve patient engagement strategies.
PharmaTech
MARCH 28, 2025
Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.
PharmExec
MARCH 28, 2025
Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.
Expert insights. Personalized for you.
320 
Let's personalize your content